Daiwa Securities Group Inc. - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5
+25.0%
1480.0%0.00%
Q2 2023$40.0%1480.0%0.00%
Q1 2023$4
+33.3%
1480.0%0.00%
Q4 2022$3
-99.8%
148
+66.3%
0.00%
Q3 2022$2,0000.0%890.0%0.00%
Q2 2022$2,0000.0%890.0%0.00%
Q1 2022$2,000
+100.0%
890.0%0.00%
Q4 2021$1,000890.00%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,566,912$62,278,0004.80%
RiverVest Venture Management LLC 1,921,118$33,543,0003.68%
Burrage Capital Management LLC 161,628$2,822,0002.15%
AIGH Capital Management LLC 274,583$4,794,0001.95%
NEA Management Company, LLC 4,187,801$73,119,0001.93%
Novo Holdings A/S 2,445,147$42,692,0001.83%
Sio Capital Management, LLC 494,743$8,638,0001.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$60,218,0001.19%
Rock Springs Capital Management LP 1,496,525$26,129,0000.55%
Prosight Management, LP 60,250$1,052,0000.49%
View complete list of MIRUM PHARMACEUTICALS INC shareholders